Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$18.10
-1.79%
Mkt Cap $2.62B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
Implied Upside
+38.2%
Consensus $25.00 vs current $18.10
NASDAQ·Healthcare·Biotechnology
$18.10
-1.79%
Mkt Cap $2.62B
Buy
13
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
+38.2%
Consensus $25.00 vs current $18.10